Tottenham Acquisition I set a Dec. 30 shareholder vote on its proposed merger with Clene Nanmedicine, a deal vlaued at $542.5 million. The preliminary proxy outlines terms of the deal and includes historical financial data on the merger target. Read more.
Related Posts
Legacy Amends Warrant Agreement Ahead of Onyx Merger
The amendment calls for each of Legacy’s outstanding public warrants, and Legacy’s private placement warrants owned by certain institutional investors shall be converted into the right to receive an amount of cash and a number of shares of Class A common stock per warrant.
TPB Acquisition I Secures Loan From Sponsor for up to $3M
According to the note's terms, the SPAC is on the hook for any loaned amount whether or not it completes a merger.
FTAC Zeus Acquisition Files Prelim Proxy for Early Liquidation
Fintech-focused FTAC Zeus raised $402.5 million in a November 2021 IPO.
Golden Arrow Merger Prices $250M IPO
The new SPAC is focused on healthcare or healthcare-related infrastructure industries in the United States and other developed countries.